Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the deliverability of the Company’s market-leading intravascular ultrasound (IVUS) technology, the iLab® Ultrasound Imaging System. IVUS technology enables physicians to see detailed images inside the heart and coronary arteries. The Company said the iCross Catheter would be available immediately in the United States.
“Boston Scientific’s iCross Coronary Imaging Catheter is a powerful tool for visualizing coronary intravascular pathology, especially in patients with complex coronary artery disease,” said Augusto Pichard, M.D., Director, Cardiac Catheterization Lab, Washington Hospital Center. “The combination of the iCross’ outstanding image quality and excellent deliverability should help physicians better identify lesion characteristics.”
“This latest advance builds on the success of our existing Atlantis® SR Pro Catheter,” said Hank Kucheman, Senior Vice President and Group President, Cardiovascular for Boston Scientific. “We expect that the improvements iCross offers to physicians and their patients will help further solidify our leadership in intravascular ultrasound.”
The iCross Catheter features a Bioslide® Hydrophilic Coating that has been shown in bench tests to provide a 28 percent improvement in pushability in challenging anatomy.
Source: Boston Scientific